Factors associated with non-adherence to antihypertensive treatment in a Social Security Health hospital in Chiclayo during the state of health emergency due to COVID-19
DOI:
https://doi.org/10.35434/rcmhnaaa.2022.151.1169Abstract
Background: Previous studies indicate poor therapeutic adherence in hypertensive patients, however, evidence on factors is limited. Objective: To determine the factors associated with non-adherence to antihypertensive treatment in a Social Health Security hospital in Chiclayo, Peru during November-December 2020. Material and Methods: Analytical cross-sectional study in adult patients with chronic diseases at Hospital I Naylamp, to whom the Morisky-Green questionnaire was applied to measure therapeutic adherence and the Bonilla and Gutiérrez instrument to evaluate factors that influence adherence to pharmacological treatment. Results: Of 234 participants, the non-adherence frequency was 52,7%, of these 68,7% were women and the main age was 71,82 + 9,15 years. In the simple regression, disease time was positively associated with non-adherence to treatment (RP: 1.02, 95%CI. Additionally, socio-economic factors related to the provider, therapy and patient were associated with a lower frequency of non-adherence to treatment. In multiple regression, people at risk of not developing treatment adherence behaviors due to socio-economic factors (RP: 0.67, 95%CI: 0,50-0,91) and to factors related to provider (RP: 0.71, 95%CI:0,54-0,92) have lower frequency of non-adherence to treatment compared to those that haver adherence. Conclusion: 5 to 6 out of 10 patients presented non-adherence to their antihypertensive treatment. Socio-economic factors, provider-related factors and patient-related factors were associated with a lower frequency of not developing adherence behaviors to their treatment.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Angela Dorelly Velasquez Montenegro, Marco Dávila Uriarte, Mario J. Valladares-Garrido
This work is licensed under a Creative Commons Attribution 4.0 International License.